Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015 Jul;15(7):592-3.

Author's Reply

Comment

Author's Reply

Nermin Bayar et al. Anatol J Cardiol. 2015 Jul.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Bayar N, Kurtoğlu E, Arslan Ş, Erkal Z, Çay S, Çağırcı G, et al. Assessment of the relationship between fragmented QRS and cardiac iron overload in patients with beta-thalassemia major’. Anatol J Cardiol. 2015;15:1326. [CrossRef] - PMC - PubMed
    1. Pathere A, Taher A, Daar S. Deferasirox significantly improves cardiac T2*in heavily iron-overloaded patients with β-thalassemia major. Ann Hematol. 2010;89:405–9. [CrossRef] - PMC - PubMed
    1. Pennell DJ, Porter JB, Cappellini MD, Chan LL, El-Beshlawy A, Aydınok Y, et al. Deferasirox for up to 3 years to continued improvement of myocardial T2*in patients with β-thalassemia major. Haematologica. 2012;97:842–8. [CrossRef] - PMC - PubMed
    1. Pennell DJ, Porter JB, Piga A, Lai Y, El-Beshlawy A, Belhoul KM, et al. A 1-year randomized controlled trial of deferasirox vs deferoxamine for myocardial iron removal in β-thalassemia major (CORDELIA) Blood. 2014;123:1447–54. [CrossRef] - PMC - PubMed
    1. Pepe A, Meloni A, Rossi G, Cuccia L, D’Ascola GD, Santodirocco M, et al. Cardiac and hepatic iron and ejection fraction in thalassemia major: Multicentre prospective comparison of combined deferiprone and deferoxamine therapy against deferiprone or deferoxamine monotherapy. J Cardiovasc Magn Reson. 2013;15:1. [CrossRef] - PMC - PubMed

LinkOut - more resources